Skin Conditioning
NICOTINOYL PENTAPEPTIDE-20
Safety score · 0–100
Fine
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
A pentapeptide conjugated to nicotinic acid (niacin). Designed to deliver niacin-like signalling with peptide-driven skin affinity.
Nicotinoyl pentapeptide-20 is a hybrid molecule: a 5-residue synthetic peptide acylated with nicotinic acid (vitamin B3/niacin). The rationale is to combine the established skin-barrier benefits associated with niacin-family ingredients with the targeted delivery profile of short peptides. Niacinamide itself has a robust CIR/SCCS safety record; nicotinic acid can cause transient flushing but typical topical esterified concentrations are far below symptomatic thresholds. This specific conjugate has not been independently reviewed by CIR or SCCS, and most efficacy data is supplier-generated. Use levels are in the ppm range.
Function
Skin benefits
- Niacin-linked barrier signalling
- Peptide improves formulation integration
- Low irritation at use levels
Known concerns
- Flush potential if hydrolysis releases free niacin in-skin
- Limited independent evidence
- No regulatory monograph for the conjugate
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related skin conditionings
Check your shelf
Find NICOTINOYL PENTAPEPTIDE-20 in your products.
Scan any cosmetic product with LuxSense to see if it contains NICOTINOYL PENTAPEPTIDE-20 and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.